DHX34 and cancer: Furthermore, our research has uncovered an association between DHX34 overexpression and reduced sensitivity of cancer cells to multiple anticancer drugs, which provides a compelling rationale that DHX34 may act as a target for cancer-specific chemotherapeutic agents.